The Defense Health Agency awarded a $1,041,595.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The three-year award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. UCSF, a prominent academic medical center and research institution, will conduct innovative...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The Defense Health Agency has awarded a $860,998.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support a 3-year research project focused on "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS", with a performance period from April 1, 2025 to March 31, 2028. The research aims to advance the scientific...
The federal Project Grant award of $1,008,313.00 was provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant, awarded on September 1, 2024, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The award will fund innovative scientific investigations spanning basic, applied,...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...